帕博利珠单抗治疗初治PD-L1阳性局部晚期/转移性非小细胞肺癌:KEYNOTE-042中国拓展研究
评价者:周清

Pembrolizumab in Previously Untreated Chinese Patients With PD-L1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer: KEYNOTE-042 China Extension Study
Reviewer: ZHOU Qing